Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
73.68
+0.93 (1.28%)
Nov 20, 2024, 4:00 PM EST - Market closed
PRAX Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for PRAX stock have an average target of 146.33, with a low estimate of 48 and a high estimate of 270. The average target predicts an increase of 98.60% from the current stock price of 73.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +62.87% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $151 | Strong Buy | Reiterates | $151 | +104.94% | Nov 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $143 → $163 | Buy | Maintains | $143 → $163 | +121.23% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +62.87% | Sep 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $151 | Strong Buy | Reiterates | $151 | +104.94% | Sep 5, 2024 |
Financial Forecast
Revenue This Year
1.46M
from 2.45M
Decreased by -40.34%
Revenue Next Year
982.26K
from 1.46M
Decreased by -32.72%
EPS This Year
-9.08
from -18.69
EPS Next Year
-10.00
from -9.08
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.1M | 3.2M | 99.2M | ||
| Avg | 1.5M | 982,260 | 46.0M | ||
| Low | 784,000 | n/a | 784,000 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -14.2% | 115.8% | 10,001.7% | ||
| Avg | -40.3% | -32.7% | 4,583.7% | ||
| Low | -68.0% | - | -20.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.07 | -6.23 | -4.48 | ||
| Avg | -9.08 | -10.00 | -9.17 | ||
| Low | -10.17 | -12.06 | -18.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.